DJIA38904.04 307.06
S&P 5005204.34 57.13
NASDAQ16248.52 199.44
Russell 20002060.10 8.70
German DAX18163.94 -238.49
FTSE 1007911.16 -64.73
CAC 408061.31 -90.24
EuroStoxx 505013.35 -57.20
Nikkei 22538992.08 -781.06
Hang Seng16723.92 -1.18
Shanghai Comp3069.30 -5.66
KOSPI2714.21 -27.79
Bloomberg Comm IDX102.90 0.64
WTI Crude-fut91.17 0.01
Brent Crude-fut86.57 1.15
Natural Gas1.79 0.00
Gasoline-fut2.79 -0.01
Gold-fut2345.40 33.50
Silver-fut27.50 0.46
Platinum-fut940.60 -5.50
Palladium-fut1007.40 -23.60
Copper-fut423.60 1.85
Aluminum-spot1815.00 0.00
Coffee-fut212.50 5.75
Soybeans-fut1185.00 5.00
Wheat-fut567.25 11.00
Bitcoin67976.00 304.00
Ethereum USD3328.10 56.27
Litecoin98.71 0.69
Dogecoin0.18 0.00
EUR/USD1.0862 0.0007
USD/JPY151.72 -0.02
GBP/USD1.2678 0.0016
USD/CHF0.9044 -0.0014
USD IDX104.28 0.08
US 10-Yr TR4.4 0.091
GER 10-Yr TR2.406 0.007
UK 10-Yr TR4.064 -0.005
JAP 10-Yr TR0.771 -0.004
Fed Funds5.5 0
SOFR5.32 0

Sub Markets

Topics

Alternative Assets  + Hedge Funds  + Private Equity  | 
Rising PE Firm Catalio Capital Management to Buy Hedge Fund Healthcor

Rising PE Firm Catalio Capital Management to Buy Hedge Fund Healthcor

Up and coming Catalio Capital Management is acquiring HealthCor Management, a healthcare-focused hedge fund founded by veteran investors Art Chen and Joe Healey.  

According to STAT News the deal is expected to close in 2023 and is mostly a stock transaction. 

Launched in 2005, HealthCor is a value-based investor dedicated to identifying global healthcare and life science equity securities that are mispriced. 

Healey and Cohen have an extensive career of investing in the sector and have co-invested for over 20 years as a team.  

Catalio Capital is a multi-strategy life sciences investment firm that manages more than $1bn in assets across its private equity, private credit and public equities strategies. 

The news follows Catalio’s close of its debut special situations fund in November – Catalio Credit Opportunities Fund I, an $85 million fund that will invest in small and mid-sized life sciences companies at various stages of growth. 

The fund is the second investment vehicle that Catalio has raised in 2022, following the close of Catalio Nexus Fund III, the firm’s third flagship private equity fund, earlier this year.

Connect

Inside The Story

Catalio Capital Management

About Joe Palmisano

Joe Palmisano is Editorial Director for Connect Money, where he brings nearly three decades experience of market insights as a financial journalist, analyst and senior portfolio manager for leading financial publications, advisory firms, and hedge funds. In his role as Editorial Director, Joe is responsible for the selection of content and creation of daily business news covering the financial markets, including Alternative Assets, Direct Investment and Financial Advisory services. Before joining Connect Money, Joe was a financial journalist for the Wall Street Journal, regularly publishing feature stories and trend pieces on the foreign exchange, global fixed income and equity markets. Joe parlayed his experience as a financial journalist into roles as a Senior Research Analyst and Portfolio Manager, writing daily and weekly market analysis and managing a FX and US equity portfolio. Joe was also a contributing writer for industry magazines and publications, including SFO Magazine and the CMT Association. Joe earned a B.S.B.A. in Finance from The American University. He holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.